StockData

Endovia Health Sciences, Inc. (EDVA) stock

EDVANYSEBeveragesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 0/30
$0.18+0.02 (+13.45%)

Close on Nov 13, 2026Market cap $137.15KP/E –Yield –

Earnings

Endovia Health Sciences's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue, Q2 FY2023
$5.20M
+8.3% on a year earlier
EPS, Q2 FY2023
-$0.13
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Endovia Health Sciences's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q2 FY2026ended Jun 30, 2026Aug 20, 2026before the open–––Release
Q2 FY2023ended Jun 30, 2023Aug 16, 2023after the close$5.20M+8.3%-$0.13Release
Q3 FY2022ended Sep 30, 2022Nov 17, 2022during market hours$4.87M+72.3%-$0.14Release
Q2 FY2022ended Jun 30, 2022Aug 16, 2022after the close$4.80M––Release
Q1 FY2022ended Mar 31, 2022May 17, 2022after the close$4.10M––Release
Q3 FY2021ended Sep 30, 2021Nov 17, 2021during market hours$2.83M––Release
Q2 FY2021ended Jun 30, 2021Aug 18, 2021during market hours–––Filing
Q1 FY2021ended Mar 31, 2021May 14, 2021after the close–––Filing
Q3 FY2020ended Sep 30, 2020Nov 17, 2020after the close–––Filing
Q2 FY2020ended Jun 30, 2020Aug 18, 2020after the close–––Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Endovia Health Sciences has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Endovia Health Sciences puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Endovia Health Sciences filed with the SEC as exhibits to Form 8-K or 6-K

  1. Endovia and Lupvindol BioSciences Announce FDA Determination
    Update
  2. Endovia Health Sciences Closes Initial $500,000 Financing
    Update
  3. Endovia Health Sciences Welcomes Historic Shift in Federal Cannabinoid
    Update
  4. Endovia Health Sciences, formerly Splash Beverage, Achieves First FDA
    Update
  5. Splash Beverage Group to Become Endovia Health Sciences; New NYSE American
    Update
  6. Splash Beverage Reports Second Quarter 2026 Results and Highlights Strategic
    Results
  7. Splash Beverage Group to Rebrand as Endovia Health Sciences
    Update
  8. SPLASH BEVERAGE GROUP PARTNERS WITH VETERAN CANNABINOID DRUG-DEVELOPMENT
    Update
  9. Splash Beverage Group Expands CannEpil® Platform
    Update
  10. Splash Beverage Group Expands CannEpil® Platform
    Update
  11. Splash Beverage Group Announces Significant Balance
    Update
  12. Splash Beverage Group Receives NYSE American Acceptance
    Update
  13. SPLASH BEVERAGE GROUP ACQUIRES EXCLUSIVE GLOBAL RIGHTS TO CANNEPIL®,
    Update
  14. SPLASH BEVERAGE GROUP INVESTS IN AVICANNA, A LEADING CANNABINOID BIOPHARMACEUTICAL
    Update
  15. Splash Beverage Group Provides Corporate Update on
    Update

See a number that looks wrong?